Physician profile
Travis Eason
NPI 1336672534
$27,316.90
in general payments reported to CMS, 2019-2025
7 companies · $106 in 2025
The $106 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $33.16 · 2022: $12K · 2023: $15K · 2024: $321 · 2025: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $10K · Travel and Lodging: $3,290 · Food and Beverage: $2,279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $10,000.00 |
| Travel and Lodging | $3,289.88 |
| Food and Beverage | $2,278.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $22,332.58 | 2022-2025 | Journey II, Polarcup, Legion Revision |
| Zimmer Biomet Holdings, INC. | $2,457.35 | 2022-2024 | Avenir, Persona |
| Stryker Corporation | $2,147.48 | 2021-2023 | Mako, Insignia, Triathlon |
| Medtronic, INC. | $237.68 | 2022 | |
| Curonix LLC | $92.36 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Vertex Pharmaceuticals Incorporated | $31.33 | 2025 | |
| Davol INC. | $18.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Eason listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.